Private Client Services LLC bought a new stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 3,667 shares of the company’s stock, valued at approximately $298,000.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Allworth Financial LP acquired a new stake in shares of VanEck Pharmaceutical ETF in the 4th quarter worth $28,000. Northwestern Mutual Wealth Management Co. acquired a new stake in shares of VanEck Pharmaceutical ETF during the 4th quarter worth about $34,000. JPMorgan Chase & Co. acquired a new position in VanEck Pharmaceutical ETF in the 4th quarter valued at about $46,000. Comerica Bank acquired a new position in VanEck Pharmaceutical ETF in the 3rd quarter valued at about $59,000. Finally, Cary Street Partners Investment Advisory LLC acquired a new position in VanEck Pharmaceutical ETF in the 3rd quarter valued at about $60,000.
VanEck Pharmaceutical ETF Stock Down 0.0 %
PPH stock opened at $85.44 on Tuesday. The stock has a market cap of $516.06 million, a price-to-earnings ratio of 16.59 and a beta of 0.72. VanEck Pharmaceutical ETF has a fifty-two week low of $74.05 and a fifty-two week high of $91.16. The business has a 50 day moving average price of $88.96 and a 200 day moving average price of $83.31.
VanEck Pharmaceutical ETF Dividend Announcement
VanEck Pharmaceutical ETF Profile
The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.
Further Reading
- Five stocks we like better than VanEck Pharmaceutical ETF
- What is a Stock Market Index and How Do You Use Them?
- Buckle Up or Bail Out? The Self-Driving Taxi Market’s Risky Ride
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Retail Investors Can Follow Goldman Sachs’ Moves This Quarter
- What Are Growth Stocks and Investing in Them
- Johnson & Johnson is as Cheap as it’s Going to Get
Want to see what other hedge funds are holding PPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report).
Receive News & Ratings for VanEck Pharmaceutical ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Pharmaceutical ETF and related companies with MarketBeat.com's FREE daily email newsletter.
